June 12, 2014 | Thornton Law Firm Share: Posted by Marilyn McGoldrick on Jun 12, 2014 11:51:51 AM You may have heard a radio or television advertisement targeting men concerning a condition known as “Low T” – shorthand for low testosterone. The ads sell testosterone replacement therapies as a way of combating “Low T.” The ads list “symptoms” of the condition that commonly occur as men age: decreased libido, fatigue and loss of energy, and decrease in strength. On January 31, 2014, the Food and Drug Administration (FDA) issued a drug safety communication about testosterone replacement therapies, announcing that it would be investigating the risk of stroke, heart attack, and early death in men taking these prescriptions. The FDA based its decision on 2 large new studies tying testosterone replacement with cardiovascular issues. A study, of men in the VA medical system, “suggested a 30 percent increased risk of stroke, heart attack, and death in the group that had been prescribed testosterone therapy”. The more recent study, funded by the National Institutes of Health (NIH), found that the risk of heart attack more than doubled for men over 65 taking the drug for 90 days, and almost tripled for men under 65 with a history of heart disease. The United States Judicial Panel on Multidistrict Litigation has ordered (pdf) that all federal claims based on injuries caused by testosterone replacement therapies, known by the sobriquet “Low T”, will be consolidated for pretrial purposes in an MDL in the Northern District of Illinois, assigned to the Honorable Judge Matthew F. Kennelly. The order applies to all 45 claims pending in four districts around the country, which will now be part of a MDL known as In re: Testosterone Replacement Therapy Products Liability Litigation. Testosterone levels vary through a man’s life, and are known to decline naturally as a man ages. But scientists have discovered that levels of testosterone in men have been falling for the last 2 decades, about 1% per year according to a study published in 2006 in The Journal of Clinical Endocrinology and Metabolism. Accordingly, prescription testosterone supplements have become a big business in recent years. It is estimated that $2 billion worth of Low T supplements were sold in 2012, and it is projected that sales will reach $5 billion by 2015. Up to 25% of prescriptions are written by doctors who haven’t given the patient a blood test, or checked hormonal levels, according to the New York Times. Thornton Law Firm is currently investigating claims on behalf of men prescribed testosterone replacement therapy who have suffered cardiovascular events including heart attack, stroke, pulmonary embolism, deep vein thrombosis, or even death. If you or a loved one has suffered a severe cardiovascular injury after taking Low T therapy, contact one of our Boston Low T attorneys today by calling 1-888-341-1405 or by telling us your story here. The consultation is free and confidential.